Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C5orf51 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
mRNA | NREP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | VGLL3 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
mRNA | CDH1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | CEP89 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
mRNA | TUBA1A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | MDFIC | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
mRNA | HOXC6 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
mRNA | PHAX | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
mRNA | AATK | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |